HUTCHMED (China) Limited
Income Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|
| Revenue | $241.2M | $216.1M | $178.2M | $87.3M |
| Cost of Revenue | $169.8M | $149.1M | $104.9M | $53.5M |
| Gross Profit | $71.4M | $66.9M | $73.3M | $33.9M |
| Gross Margin | 29.6% | 31.0% | 41.2% | 38.8% |
| Operating Expenses | ||||
| Research & Development | $75.5M | $66.9M | $47.4M | $29.9M |
| SG&A Expense | $24.0M | $21.6M | $19.6M | $12.7M |
| Operating Income | $-53.4M | $-46.7M | $-9.8M | $-18.3M |
| Operating Margin | -22.1% | -21.6% | -5.5% | -20.9% |
| Interest Expense | $1.5M | $1.6M | $1.4M | $1.5M |
| Pretax Income | $-53.5M | $20.5M | $13.4M | $-3.3M |
| Income Tax Expense | $3.1M | $4.3M | $1.6M | $1.3M |
| Net Income | $-26.7M | $11.7M | $8.0M | $-7.3M |
| Net Margin | -11.1% | 5.4% | 4.5% | -8.4% |
| EPS (Basic) | $0.00 | $0.02 | $-0.06 | $-0.06 |
| EPS (Diluted) | $-0.04 | $0.02 | $-0.06 | $-0.06 |
| Shares Outstanding (Basic) | 6.17B | 597.2M | 546.6M | 525.6M |
| Shares Outstanding (Diluted) | 617.2M | 599.7M | 546.6M | 525.6M |
| Dividends Per Share | — | — | — | — |